For research use only. Not for therapeutic Use.
Cimaterol-d7 is a deuterated form of the β-adrenergic agonist cimaterol, where seven hydrogen atoms are replaced with deuterium. This isotopically labeled compound is used in pharmaceutical research to study the pharmacokinetics, metabolism, and biological activity of cimaterol, particularly in the context of its effects on muscle growth and fat metabolism. The deuterium labeling allows for precise tracking and differentiation in mass spectrometry, making it a valuable tool for exploring the metabolic pathways and interactions of cimaterol in biological systems. Researchers use Cimaterol-d7 to gain deeper insights into the mechanisms of action of β-adrenergic agonists, contributing to the development of therapeutic strategies for conditions related to muscle wasting, obesity, and metabolic disorders.
Catalog Number | R013773 |
CAS Number | 1228182-44-2 |
Synonyms | 2-Amino-5-[1-hydroxy-2-[(1-methylethyl-d7)amino]ethyl]benzonitrile; CL 263780-d7; |
Molecular Formula | C12H17N3O |
Purity | ≥95% |
Storage | Store at RT |
IUPAC Name | 2-amino-5-[2-(1,1,1,2,3,3,3-heptadeuteriopropan-2-ylamino)-1-hydroxyethyl]benzonitrile |
InChI | InChI=1S/C12H17N3O/c1-8(2)15-7-12(16)9-3-4-11(14)10(5-9)6-13/h3-5,8,12,15-16H,7,14H2,1-2H3/i1D3,2D3,8D |
InChIKey | BUXRLJCGHZZYNE-UNAVHCQLSA-N |
SMILES | [2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])NCC(C1=CC(=C(C=C1)N)C#N)O |